Skip to content
Screener

MapLight Therapeutics, Inc. MPLT Current ratio

Current ratio at other companies

Bristol-Myers Squibb logo
Bristol-Myers SquibbBMY
1.5×+0.3×
Johnson & Johnson logo
Johnson & JohnsonJNJ
1.1×+0.1×
Neurocrine Biosciences logo
Neurocrine BiosciencesNBIX
2.9×-0.2×
Acadia Pharmaceuticals logo
Acadia PharmaceuticalsACAD
3.4×+0.5×
AbbVie logo
AbbVieABBV
0.8×0.0×
LBR
LB Pharmaceuticals IncLBRX
35.7×—

Other financials

Income statement

See full
Operating income-$64.5M-174%
Net income-$60.7M-172%
EPS (diluted)-$1.34+95.4%

Balance sheet

See full
Cash & equivalents$55.7M—
Total debt$5.6M—
Total equity$399.8M+285%
Total assets$418.8M—

Cash flow

See full
Operating cash flow-$51.2M-100%
CapEx$24.0K—
Free cash flow-$51.2M—

Valuation

See full
Market cap$602.19M-13.2%
Enterprise value$552.07M—

Returns & leverage

See full
Return on equity-216.8%—
Debt / equity0×—

Where this comes from

Calculated from MapLight Therapeutics, Inc.’s reported figures.

total current assets/total current liabilities=22.9×

Based on the most recent quarter.

The source filing: MapLight Therapeutics, Inc.’s 10-Q, filed May 14, 2026. Open the filing →

Filed
May 14, 2026, 4:25 PM EDT
Fiscal quarter
Q1 FY2026
Calendar quarter
Q1 2026
Accession
0001193125-26-224129

FAQ

What is MapLight Therapeutics, Inc.'s current ratio?
MapLight Therapeutics, Inc. (MPLT) reported current ratio of 22.9× in Q1 2026.
What does current ratio mean?
Current assets divided by current liabilities at the quarter end. Measures the company's ability to cover near-term obligations with near-term assets.

Ask your AI about MapLight Therapeutics, Inc.'s current ratio.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude